HIV Diagnostics Market is Gaining Rapid Traction

HIV diagnostics are not as simple to acquire as they may appear to be, and it's important that you get the correct tests for your particular condition. One shouldn't be embarrassed or feel ashamed about getting tested for the disease; after all, there are a lot of people who are living with HIV or AIDS and are leading happy lives. The reason you're being tested is simply so you can get the proper medical help you need, which can help you combat this dangerous disease.

The PDF for the study can be requested using the following link: https://www.coherentmarketinsights.com/insight/request-pdf/422

Growing prevalence of HIV/AIDS is expected to drive growth of the global HIV diagnostics market. According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), in 2019, 38 million people were living with HIV across the globe, of which 36.2 million were adults and 1.8 million were children aged 15 years and below. According to the same source, around 1.7 million people across the globe acquired HIV in 2019. Such increasing prevalence has led to high demand for advanced HIV diagnostics devices and testing kits across the globe. Hence, such factors are expected to drive growth of the global HIV diagnostics market.

Increasing proactive initiatives to create awareness regarding HIV/AIDS is expected to propel the global HIV diagnostics market growth in the near future. For instance, in December 2020, product of Mankind Pharma, launched a new campaign titled “#StandTogether” to raise awareness regarding HIV.

Lack of mandates for the nucleic acid test (NAT) and high costs associated with it in emerging economies is expected to restrain growth of the global HIB diagnostics market. Among regions, North America is expected to witness significant growth in the global HIV diagnostics market. This is owing to the presence of a technologically advanced healthcare network and higher expenditure in R&D. Furthermore, Asia Pacific is expected to register a robust growth rate, owing to the presence of high unmet demand in China and India.

For instance, in September 2020, Roche Diagnostics received the U.S. Food and Drug Administration (FDA) approval for its cobas HIV-1/HIV-2 Qualitative Test for use on the fully automated cobas 6800/8800 Systems in the U.S.

Exclusive offer!!! Purchase the report at a discounted rate!!!

Buy This Research Study Report With Flat US $2000 Off https://www.coherentmarketinsights.com/promo/buynow/422

Major Players In The Industry Are: Abbott Laboratories, Bio-Rad Laboratories, Inc., Hologic, Inc., Siemens Healthineers, Roche AG, Beckman Coulter Inc., OraSure Technologies, Inc., Becton, Dickinson and Company, Merck KGaA, Chembio Diagnostic Systems, Inc., Zyomyx Incorporation, Bristol –Myres Squibb, Janssen Therapeutic, QIAGEN N.V., and ViiV Healthcare Ltd.

More Related Report:

Interspinous Spacers Market - https://www.medgadget.com/2021/07/interspinous-spacers-market-global-growth-by-2026-industry-analysis-by-size-trends-competitor-strategy-high-emerging-sales-revenue-competitive-landscape-opportunity-and-challenges.html

Medical Vacuum System Market - https://www.medgadget.com/2021/07/medical-vacuum-system-market-6-6-cagr-find-out-growth-potential-through-demand-forecast-2026-cmi.html

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.